Michael Evans‐Brown

New Psychoactive Substances in Europe. An Update from the EU Early Warning System

Andrew Cunningham, Michael Evans‐Brown, A Gallegos et al. · 2015 · 142 citations

Substance Abuse, Psychoactive Drug, Health Policy +10

Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study

Vivian Hope, Jim McVeigh, Andrea Marongiu et al. · BMJ Open · 2013 · 116 citations · Full text

DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles

István Ujváry, Rachel Christie, Michael Evans‐Brown et al. · ACS Chemical Neuroscience · 2021 · 116 citations

Psychotropic Medication, Illicit Drug Market, Psychopharmacology +22

Anabolic steroids detected in bodybuilding dietary supplements – a significant risk to public health

Vincenzo Abbate, Andrew T. Kicman, Michael Evans‐Brown et al. · Drug Testing and Analysis · 2014 · 89 citations

Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking

Vivian Hope, Jim McVeigh, Andrea Marongiu et al. · Epidemiology and Infection · 2014 · 60 citations · Full text

Wound Assessment, Surgery, Injury Prevention +19